Evaluation on an introduction method of fentanyl patch by using short-acting opioid for cancer pain management in the outpatient setting. - Evaluation on an introduction method of fentanyl patch by using short-acting opioid for cancer pain management in the outpatient setting.(Miyagi-HBPCOG 008)

Tohoku University Graduate School of Medicine Division of Integrated Surgery and Oncology0 个研究点目标入组 30 人开始时间: 2011年4月26日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients with hypersensitivity to opioid Patients with medical history of opiod addiction Patients considered necessary for titration inpatient setting Patients with respiratory dysfunctions such as chronic lung disease Patients with asthma Patients with serious heart dysfunction Patients with serious hepatic or renal dysfunction Patients with intracranial hypertension and disturbed consciousness Patients with skin disease such as eczema and atopy at the attached site Patients with 40 degree or more fever Homeostatically Pregnant patients and patients who may possibly be pregnant. Patients treated with opioid antagonists such as pentazocine and buprenorphine within 2 days prior to fentanyl patch attachment. Patients under the age of 20 Patients considered as inappropriate for study by investigator

发起方

Tohoku University Graduate School of Medicine Division of Integrated Surgery and Oncology